Invariant NKT cell lines derived from the NOD·H2h4 mouse enhance autoimmune thyroiditis

Journal of Thyroid Research

Volumn 2011, Issue , 2011, Pages

  Sharma, Rajni B ^a   Fan, Xiaoguang ^a   Caturegli, Patrizio ^a   Rose, Noel R ^a,b   Burek, C Lynne ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; AUTOANTIGEN; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; IODINE; T LYMPHOCYTE RECEPTOR; THYROGLOBULIN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE THYROIDITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; DIETARY INTAKE; DISEASE EXACERBATION; DX5+ T LYMPHOCYTE; FEMALE; GENE LOCUS; GENE STRUCTURE; IMMUNOPATHOGENESIS; INCIDENCE; INVARIANT NATURAL KILLER T CELL; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; THYROID GLAND;

EID: 84880617465     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.4061/2011/895923     Document Type: Article

References (44)

1. G. S. Cooper and B. C. Stroehla, "The epidemiology of autoimmune diseases", Autoimmunity Reviews, vol. 2, no. 3, pp. 119.125, 2003.
2. D. L. Jacobson, S. J. Gange, N. R. Rose, and N. M. H. Graham, "Epidemiology and estimated population burden of selected autoimmune diseases in the United States", Clinical Immunology and Immunopathology, vol. 84, no. 3, pp. 223-243, 1997. (Pubitemid 27398022)
3. h4 mice", Clinical Immunology and Immunopathology, vol. 81, no. 3, pp. 287.292, 1996.
4. h4 mouse", Experimental and Molecular Pathology, vol. 74, no. 1, pp. 1.12, 2003.
5. h4 mice", Journal of Autoimmunity, vol. 12, no. 3, pp. 157.165, 1999.
6. E. N. Pearce, A. P. Farwell, and L. E. Braverman, "Thyroiditis" , New England Journal of Medicine, vol. 348, no. 26, pp. 2646-2655, 2003. (Pubitemid 36741593)
7. R. Furlan, A. Bergami, D. Cantarella et al., "Activation of invariant NKT cells by αGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-γ", European Journal of Immunology, vol. 33, no. 7, pp. 1830.1838, 2003.
8. M. Falcone, F. Facciotti, N. Ghidoli et al., "Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice", Journal of Immunology, vol. 172, no. 10, pp. 5908.5916, 2004.
9. A. Martín-Fontecha, L. L. Thomsen, S. Brett et al., "Induced recruitment of NK cells to lymph nodes provides IFN-γ for T1 priming", Nature Immunology, vol. 5, no. 12, pp. 1260.1265, 2004.
10. T. Griseri, L. Beaudoin, J. Novak et al., "Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells", Journal of Immunology, vol. 175, no. 4, pp. 2091.2101, 2005.
11. T. Kawamura, K. Takeda, S. K. Mendiratta et al., "Cutting edge: critical role of NK1 T cells in IL-12-induced immune responses in vivo", Journal of Immunology, vol. 160, no. 1, pp. 16.19, 1998.
12. K. J. L. Hammond, D. G. Pellicci, L. D. Poulton et al., "CD1drestricted NKT cells: an interstrain comparison", Journal of Immunology, vol. 167, no. 3, pp. 1164.1173, 2001.
13. A. Bendelac, M. N. Rivera, S.E. H. Park, and J. H. Roark, "Mouse CD1-specific NK1 T cells: development, specificity, and function", Annual Review of Immunology, vol. 15, pp. 535-562, 1997. (Pubitemid 27169416)
14. O. Lantz and A. Bendelac, "An invariant T cell receptor α chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans", Journal of Experimental Medicine, vol. 180, no. 3, pp. 1097.1106, 1994.
15. Y. Makino, R. Kanno, T. Ito, K. Higashino, and M. Taniguchi, "Predominant expression of invariant V (α) 14 TCR α chain in NK1.1 T cell populations", International Immunology, vol. 7, no. 7, pp. 1157.1161, 1995.
16. J. Mattner, K. L. De Bord, N. Ismail et al., "Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections", Nature, vol. 434, no. 7032, pp. 525.529, 2005.
17. Y. Kinjo, D. Wu, G. Kim et al., "Recognition of bacterial glycosphingolipids by natural killer T cells", Nature, vol. 434, no. 7032, pp. 520.525, 2005.
18. D. I. Godfrey, K. J. L. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter, "NKT cells: facts, functions and fallacies", Immunology Today, vol. 21, no. 11, pp. 573.583, 2000.
19. K. J. L. Hammond, S. B. Pelikan, N. Y. Crowe et al., "NKT cells are phenotypically and functionally diverse", European Journal of Immunology, vol. 29, no. 11, pp. 3768.3781, 1999.
20. N. Burdin, L. Brossay, Y. Koezuka et al., "Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates Vα14 NK T lymphocytes", Journal of Immunology, vol. 161, no. 7, pp. 3271.3281, 1998.
21. A. Hameg, I. Apostolou, M. Leite-De-Moraes et al., "A subset of NKT cells that lacks the NK1.1 Marker, expresses CD1d molecules, and autopresents the α-galactosylceramide antigen", Journal of Immunology, vol. 165, no. 9, pp. 4917-4926, 2000.
22. H. Braley-Mullen, M. Johnson, G. C. Sharp, and M. Kyriakos, "Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells", Cellular Immunology, vol. 93, no. 1, pp. 132.143, 1985.
23. H. Braley-Mullen and G. C. Sharp, "Adoptive transfer murine model of granulomatous experimental autoimmune thyroiditis", International Reviews of Immunology, vol. 19, no. 6, pp. 535.555, 2000.
24. A. M. Saboori, N. R. Rose, W. G. Butscher, and C. L. Burek, "Modification of a nonincinerative method for determination of iodine in iodoproteins", Analytical Biochemistry, vol. 214, no. 1, pp. 335.338, 1993.
25. J. P. Rosat, M. Schreyer, T. Ohteki, G. A. Waanders, H. R. MacDonald, and J. A. Louis, "Selective expansion of activated Vα4 cells during experimental infection of mice with Leishmania major", European Journal of Immunology, vol. 24, no. 2, pp. 496.499, 1994.
26. h4 mouse thyrocytes", Journal of Immunology, vol. 174, no. 12, pp. 7740.7745, 2005.
27. A. P. Weetman, "Cellular immune responses in autoimmune thyroid disease", Clinical Endocrinology, vol. 61, no. 4, pp. 405-413, 2004. (Pubitemid 39388475)
28. K. Benlagha, A. Weiss, A. Beavis, L. Teyton, and A. Bendelac, "In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers", Journal of Experimental Medicine, vol. 191, no. 11, pp. 1895-1903, 2000. (Pubitemid 30390352)
29. H. Itoh, N. Nimura, T. Kinoshita, N. Nagae, and M. Nomura, "Fast protein separation by reversed-phase high-performance liquid chromatography on octadecylsilyl-bonded nonporous silica gel: II. Improvement in recovery of hydrophobic proteins", Analytical Biochemistry, vol. 199, no. 1, pp. 7-10, 1991.
30. M. F. Van den Hove, M. Couvreur, V. Col, C. Gervy, M. Authelet, and P. Neve, "T accumulation in lysosomes of rat thyroid remnants after subtotal thyroidectomy", European Journal of Cell Biology, vol. 68, no. 4, pp. 437-445, 1995.
31. K. M. Zabel and A. B. Rawitch, "Thyroglobulin structurefunction: the effect of iodination on the structure of human thyroglobulin", Biochemical and Biophysical Research Communications, vol. 121, no. 1, pp. 310-316, 1984. (Pubitemid 14117155)
32. B. Texier, C. Bedin, H. Tang, L. Camoin, C. Laurent-Winter, and J. Charreire, "Characterization and sequencing of a 40-amino-acid peptide from human thyroglobulin inducing experimental autoimmune thyroiditis", Journal of Immunology, vol. 148, no. 11, pp. 3405-3411, 1992.
33. I. Van Rhijn, D. C. Young, J. S. Im et al., "CD1d-restricted T cell activation by nonlipidic small molecules", Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 37, pp. 13578-13583, 2004. (Pubitemid 39238445)
34. A. Giraud, J. Dicristofaro, C. De Micco, P. J. Lejeune, J. Barbaria, and B. Mallet, "A plasminogen-like protein, present in the apical extracellular environment of thyroid epithelial cells, degrades thyroglobulin in vitro", Biochemical and Biophysical Research Communications, vol. 338, no. 2, pp. 1000-1004, 2005. (Pubitemid 41597739)
35. S. Sharif, G. A. Arreaza, P. Zucker et al., "Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes", Nature Medicine, vol. 7, no. 9, pp. 1057-1062, 2001. (Pubitemid 32937388)
36. Y. N. Naumov, K. S. Bahjat, R. Gausling et al., "Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets", Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 24, pp. 13838-13843, 2001. (Pubitemid 33115985)
37. T. Kawano, J. Cui, Y. Koezuka et al., "CD1d-restricted and TCR-mediated activation of V (α) 14 NKT cells by glycosylceramides", Science, vol. 278, no. 5343, pp. 1626-1629, 1997. (Pubitemid 27516282)
38. H. Chen and W. E. Paul, "Cultured NK1.1+CD4+ T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1", Journal of Immunology, vol. 159, no. 5, pp. 2240-2249, 1997. (Pubitemid 127681014)
39. J. R. Ortaldo, H. A. Young, R. T. Winkler-Pickett, E. W. Bere, W. J. Murphy, and R. H. Wiltrout, "Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides", Journal of Immunology, vol. 172, no. 2, pp. 943-953, 2004. (Pubitemid 38113753)
40. K. Miyamoto, S. Miyake, and T. Yamamura, "A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing T2 bias of natural killer T cells", Nature, vol. 413, no. 6855, pp. 531-534, 2001. (Pubitemid 32938752)
41. J. B. Margolick, A. P. Weetman, and K. D. Burman, " Immunohistochemical analysis of intrathyroidal lymphochytes in Graves' disease: evidence of activated T cells and production of interferon-γ", Clinical Immunology and Immunopathology, vol. 47, no. 2, pp. 208-218, 1988.
42. A. K. Singh, J. Q. Yang, V. V. Parekh et al., "The natural killer T cell ligand α-galactosylceramide prevents or promotes pristane-induced lupus in mice", European Journal of Immunology, vol. 35, no. 4, pp. 1143-1154, 2005. (Pubitemid 40542221)
43. H. Y. Kim, H. J. Kim, H. S. Min et al., "NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production", Journal of Experimental Medicine, vol. 201, no. 1, pp. 41-47, 2005. (Pubitemid 40130082)
44. L. Wu and L. Van Kaer, "Natural killer T cells and autoimmune disease", Current Molecular Medicine, vol. 9, no. 1, pp. 4-14, 2009.